Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis.
Liver Int
; 39(4): 705-713, 2019 04.
Article
in En
| MEDLINE
| ID: mdl-30637923
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Propranolol
/
Adrenergic beta-Antagonists
/
Metabolomics
/
Hypertension, Portal
/
Liver Cirrhosis
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2019
Type:
Article